Sex, Gender, and the Regulation of Prescription Drugs: Omissions and Opportunities

The regulation of prescription drugs is an important health, safety, and equity issue. However, regulatory processes do not always consider evidence on sex, gender, and factors such as age and race, omissions that advocates have highlighted for several decades. Assessing the impact of sex-related fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Greaves, Lorraine, Brabete, Andreea C., Maximos, Mira, Huber, Ella, Li, Alice, Lê, Mê-Linh, Eltonsy, Sherif, Boscoe, Madeline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962082/
https://www.ncbi.nlm.nih.gov/pubmed/36833654
http://dx.doi.org/10.3390/ijerph20042962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962082/
https://www.ncbi.nlm.nih.gov/pubmed/36833654
http://dx.doi.org/10.3390/ijerph20042962

Ejemplares similares